|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-12-19
|
|
pubmed:abstractText |
In a syngeneic mouse brain tumor model, we tested the hypothesis that vaccination with tumor cells genetically modified to express B7.1 molecules induces tumor-specific T cells and immunological antitumor effects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0148-396X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
182-9; discussion 189-90
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14683556-Adenoviridae,
pubmed-meshheading:14683556-Animals,
pubmed-meshheading:14683556-Antigens, CD80,
pubmed-meshheading:14683556-Avian Sarcoma Viruses,
pubmed-meshheading:14683556-Brain Neoplasms,
pubmed-meshheading:14683556-Cell Line, Tumor,
pubmed-meshheading:14683556-Disease Models, Animal,
pubmed-meshheading:14683556-Gene Expression,
pubmed-meshheading:14683556-Gene Transfer Techniques,
pubmed-meshheading:14683556-Genetic Vectors,
pubmed-meshheading:14683556-Glioma,
pubmed-meshheading:14683556-Immunotherapy, Active,
pubmed-meshheading:14683556-Mice,
pubmed-meshheading:14683556-Mice, Inbred C3H
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Vaccine therapy for murine glioma using tumor cells genetically modified to express B7.1.
|
|
pubmed:affiliation |
Department of Neurosurgery, Yamaguchi University School of Medicine, Yamaguchi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
